Wide Scale Testing Beginning for COVID-19 Vaccines

Researchers are making so much progress in developing a vaccine against COVID-19 that the first wide-scale testing could begin in a matter of weeks.

The New York Times Coronavirus Vaccine Tracker says a vaccine developed by the 10-year-old biotech company Moderna expects to start wide-scale testing this month. If it does, it would mark an almost unprecedented acceleration of the clinical testing process.

Typically, testing and approving a new vaccine takes two or three years. Sometimes more. But under the federal government’s Operation Warp Speed, Modena received a fast-track designation from the Food and Drug Administration. It also got a $483 million award to further its Covid-19 vaccine.

Through its Coronavirus Vaccine Tracker The Times is updating the status of all the vaccines that have reached human testing, along with a selection of promising vaccines still being tested in cells or animals. Because of the number and especially speed at which bioscience and pharmaceutical firms are moving to develop a successful vaccine, the Tracker is being updated almost every day.

The World Health Organization lists 149 different vaccine projects underway worldwide. 17 are in clinical evaluation, meaning they are being tested in humans, either in small groups to ensure their safety and basic efficacy, or in hundreds to see the effect among different age groups.

The Vaccine Tracker lists five vaccine candidates that are in or about to launch Phase III testing, the broadest testing category where thousands of volunteers are enlisted to determine if the vaccine is widely effective and how well it protects people from becoming infected. That’s the test Moderna expects to begin soon.

A vaccine developed by AstraZeneca and the University of Oxford is already in Phase III testing in Brazil and South Africa and is in a simultaneous Phase II and III study in Europe. This program, like Moderna’s, is part of Operation Warp Speed.

The Vaccine Tracker lists two Chinese firms – Sinovac Biotech and Sinopharm – as ready to soon start broad testing of their respective vaccines. Sinopharm’s testing will be conducted in the United Arab Emirates. Sinovac plans to conduct its Phase III study in China and Brazil.

A fifth vaccine, which is not a vaccine specifically for COVID-19, but a sort of immune system booster, is being tested in Australia. Bacillus Calmette-Guerin, a vaccine originally developed for tuberculosis, has been found over its 100 year history to help fight off other types of infections and parasites. The Phase III testing will determine if it also helps protect against COVID-19.

Image by Angelo Esslinger

Resume Tricks for 2022
General Interest Green Key News Worklife

Resume Tricks for 2022

#WeAreGreenKey: Spotlight on Kornelia Klukowska
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Kornelia Klukowska

When to Say Goodbye to a Candidate
General Interest Green Key News Worklife

When to Say Goodbye to a Candidate

#WeAreGreenKey: Spotlight on Allison Vogt
General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Allison Vogt

Green Key Unlocked: The Growth of Professional Support
General Interest Green Key News Professional Support Worklife

Green Key Unlocked: The Growth of Professional Support

#WeAreGreenKey: Spotlight on Brittany Leader
General Interest Green Key News Healthcare Worklife

#WeAreGreenKey: Spotlight on Brittany Leader

Green Key Unlocked: FAQs of Working with a Recruiter
General Interest Green Key News Pharma Worklife

Green Key Unlocked: FAQs of Working with a Recruiter

Green Key Announces New Senior Partners
General Interest Green Key News Worklife

Green Key Announces New Senior Partners

Green Key Against Gun Violence
General Interest Green Key News

Green Key Against Gun Violence

How to Support Mental Health in the Workplace
General Interest Green Key News Worklife

How to Support Mental Health in the Workplace

#WeAreGreenKey: Spotlight on Larry Goodman
General Interest Green Key News Pharma Worklife

#WeAreGreenKey: Spotlight on Larry Goodman

#WeAreGreenKey: Spotlight on Mike Glock
Accounting + Finance Financial Services General Interest Worklife

#WeAreGreenKey: Spotlight on Mike Glock

How to Make Your Candidate an Attractive Offer
General Interest Green Key News Worklife

How to Make Your Candidate an Attractive Offer

Tips for Recent Grads
General Interest Green Key News Worklife

Tips for Recent Grads

#WeAreGreenKey: Spotlight on Patrick Friel
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Patrick Friel

Working Moms at GKR
General Interest Green Key News Healthcare Human Resources Pharma Professional Support Worklife

Working Moms at GKR

Green Key Resources Opens New Jersey Office
General Interest Green Key News Worklife

Green Key Resources Opens New Jersey Office

#WeAreGreenKey: Spotlight on Tim Durkin
Accounting + Finance General Interest Green Key News Worklife

#WeAreGreenKey: Spotlight on Tim Durkin

Green Key Unlocked: Onboarding & Training in Agency Recruiting
General Interest Green Key News Worklife

Green Key Unlocked: Onboarding & Training in Agency Recruiting

How to Beat Work from Home Fatigue
General Interest Green Key News Worklife

How to Beat Work from Home Fatigue

Latest Blog Posts
View All Posts
Resume Tricks for 2022

Resume Tricks for 2022

To keep you on top of the resume trends, we've put together a comprehensive list of tricks and tips to...
Read More
#WeAreGreenKey: Spotlight on Kornelia Klukowska

#WeAreGreenKey: Spotlight on Kornelia Klukowska

Coming directly from the accounting industry, Kornelia started her recruiting career six months ago and is already succeeding tremendously in...
Read More
When to Say Goodbye to a Candidate

When to Say Goodbye to a Candidate

As a recruiter, you will come across many talented and attentive individuals. However, there will always be candidates who display...
Read More